Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Checking in on Gold & Silver Sentiment

The precious metals sector remains in a correction. The miners have shown some positive signs but are not ready to move yet because the metals likely have more correction ahead. Technical support levels can provide us with low risk buy opportunities but combine that with s...
Jordan Roy-Byrne, CMT | November 27, 2019 |

Silver options strategies that could be lucrative for investors

In last Wednesday's Money Morning special report on silver , several of our financial gurus projected higher prices ahead for "the other precious metal." Since then, silver has climbed about 5% -- hitting $43 an ounce yesterday (Monday). Silver is now nearing its record ...
Larry D. Spears | October 28, 2012 |

Biopharma Continues 'Positive Push Forward in Breast Cancer'

The latest clinical trial results and next step are reviewed in an H.C. Wainwright & Co. report. In a Dec. 26 research note, analyst Joseph Pantginis reported that H.C. Wainwright & Co. increased its target price to AU$0.20 from AU$0.16 and maintained its Buy recommen...
Streetwise Reports | December 30, 2019 |

Coverage Initiated on Immunotherapies Developer with 'Catalyst Rich 2020'

The key business and investment points are presented in a ROTH Capital Partners report. In a Dec. 18 research note, analyst Jonathan Aschoff reported that ROTH Capital Partners initiated coverage on Inovio Pharmaceuticals Inc. (INO:NASDAQ) with a Buy rating and a "c...
Streetwise Reports | December 27, 2019 |

A New and Exciting, Near-Surface, High-Grade Uranium Discovery in the Athabasca Basin

What do you get when you combine some of the best uranium geologists in the world, a world-class project in a mining-friendly jurisdiction, and a green energy fuel that is the most reliable and a cost-efficient baseload power source for the world? You get Baselode Energy C...
Dave Jackson | January 25, 2022 |

Syros Pharma Teams Up with Global Blood Therapeutics to Fight Sickle Cell Disease

Syros Pharmaceuticals' shares rose 20% today after the firm reported that it entered into a collaboration agreement with Global Blood Therapeutics for development of therapies for sickle cell disease and beta thalassemia that could result in payments to Syros as high as $315 m...
Streetwise Reports | December 19, 2019 |

Leap Therapeutics Lunges Forward on $132M Licensing Deal and $27M Equity Raise

Shares of Leap Therapeutics jumped 60% after the company reported that it signed an exclusive option and license agreement for its immuno-oncology drug DKN-01 with BeiGene in the Asia Pacific region excluding Japan. The firm also secured an additional $27 million in equity fin...
Streetwise Reports | January 6, 2020 |

Domo Posts 19% Growth in Q1 FY21 Revenue

Shares of cloud platform provider Domo Inc. traded 15% higher and set a new 52-week high price after the company reported Q1 FY21 financial results that included a 19% increase in y-o-y revenue. Cloud-based business platform company Domo Inc. (DOMO:NASDAQ) yester...
Streetwise Reports | June 8, 2020 |

Invitae Corp. Enters into Definitive Agreement to Acquire ArcherDX

Shares of Invitae Corp. traded 40% higher after the company reported it will acquire ArcherDX in a combination cash and stock deal valued at around $1.4 billion. Advanced medical genetics company Invitae Corp. (NVTA:NYSE) and genomics analysis firm ArcherDX today...
Streetwise Reports | June 23, 2020 |

A Unique Opportunity in the Green Energy Arena

Green hydrogen is generated using renewable energy or from low-carbon power, which equates to much lower carbon emissions than traditional grey hydrogen, which still makes up the bulk of the hydrogen market. As that market grows, Québec-based Charbone Hydrogen is posi...
Simon Druker | October 13, 2022 |
1 2 3 4 5 6 7 8 9 10 ...